We found two drugs, JNJ-40346527 (CSF1R inhibitor) and Emactuzumab (anti-CSF1R monoclonal antibody; Fig. 4a), which have been extensively used in oncology58 but never to treat Alzheimer’s disease. Here, CSF1R is linked to early-onset autosomal dominant Alzheimer disease.